Initiate
Initiate is a global health economics and market access consultancy with decades of experience. They specialize in delivering bespoke solutions throughout a product's lifecycle, including early strategic pricing, payer research, local HTAs, and health technology assessments. With a success rate of 98% for over 130 HTA submissions, they work with top pharmaceutical companies, med-tech, and medical device clients, primarily in rare and complex diseases. Their team combines deep industry knowledge, data presentation expertise, and insider perspectives to support clients in achieving successful market access and reimbursement outcomes.
Industries
Nr. of Employees
small (1-50)
Initiate
London, England, United Kingdom, Europe
Services
Tailored HTA services including strategy development, submission writing, health economic modelling, literature reviews, indirect treatment comparisons and post-submission support.
Health economic modelling, systematic and targeted literature reviews, meta-analyses, indirect treatment comparisons, feasibility studies and real-world evidence generation.
Value demonstration and dossier development, payer value proposition testing, launch sequencing, price strategy and access launch planning.
Pricing strategy, pricing research, international reference pricing analysis, forecast development and pricing/reimbursement submission support.
Qualitative and quantitative payer and clinician research including modified Delphi, advisory boards, interviews, surveys, MCID and vignette studies to validate clinical and economic inputs.
In-licensing assessment, price evaluation, forecasting, reimbursement route assessment and testing for market opportunity and asset positioning.
Tailored HTA services including strategy development, submission writing, health economic modelling, literature reviews, indirect treatment comparisons and post-submission support.
Health economic modelling, systematic and targeted literature reviews, meta-analyses, indirect treatment comparisons, feasibility studies and real-world evidence generation.
Value demonstration and dossier development, payer value proposition testing, launch sequencing, price strategy and access launch planning.
Pricing strategy, pricing research, international reference pricing analysis, forecast development and pricing/reimbursement submission support.
Qualitative and quantitative payer and clinician research including modified Delphi, advisory boards, interviews, surveys, MCID and vignette studies to validate clinical and economic inputs.
In-licensing assessment, price evaluation, forecasting, reimbursement route assessment and testing for market opportunity and asset positioning.
Expertise Areas
- Health technology assessment (HTA)
- Health economics and outcomes research (HEOR)
- Market access strategy
- Pricing and reimbursement
Key Technologies
- Health economic modelling
- Cost-effectiveness analysis
- Budget impact modelling
- Cost-consequence and cost-minimisation analysis
News & Updates
Major conference in Amsterdam from 27th to 29th October 2025.
Conference in Glasgow, Scotland from 9th to 12th November 2025.
Major conference in Amsterdam from 27th to 29th October 2025.
Conference in Glasgow, Scotland from 9th to 12th November 2025.